✓
Open
18 Jun 2025
✓
Close
20 Jun 2025
3
Allotment
—
✓
Listing
Wed, Jun 25, 2025
Price Band
₹91 to ₹96
Issue Size
61,00,800 shares (agg. up to ₹59 Cr)
Lot Size
1,200 Shares
Listing Date
Wed, Jun 25, 2025
Latest GMP
₹20
Est. Gain
20.83%
✦ AI Insight
GMP Trend
25-06-2025₹20Est. ₹116+20.83%
24-06-2025₹20Est. ₹116+20.83%
23-06-2025₹17Est. ₹113+17.71%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 141.07x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 70.30 | 41.10 | 28.30 |
| Total Income | 104.99 | 100.10 | 76.07 |
| Profit After Tax | 13.37 | 11.22 | 7.20 |
| NET Worth | 36.15 | 22.87 | 11.65 |
| Reserves and Surplus | 18.00 | 22.85 | 11.63 |
| Total Borrowing | 0.22 | 0.32 | 0.80 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Astonea Labs Ltd. | SME | ₹37.67 Cr | ₹135 | 27.36 | ₹135.65 | +0.48% | ₹278.00 (-1.77%) |
| Accretion Pharmaceuticals Ltd. | SME | ₹29.75 Cr | ₹101 | 21.29 | ₹82.95 | -17.87% | ₹165.65 (-0.21%) |
| Amwill Health Care Ltd. | SME | ₹59.98 Cr | ₹111 | 13.81 | ₹93.25 | -15.99% | ₹43.39 (+3.04%) |
| Sat Kartar Shopping Ltd. | SME | ₹33.80 Cr | ₹81 | 14.87 | ₹161.55 | +99.44% | ₹126.60 (-2.62%) |
| Onyx Biotec Ltd. | SME | ₹29.34 Cr | ₹61 | 26.81 | ₹56.75 | -6.97% | ₹37.60 (-4.93%) |
| Medicamen Organics Ltd. | SME | ₹10.54 Cr | ₹34 | 30.53 | ₹144.70 | +325.59% | ₹22.90 (-0.43%) |
| Senores Pharmaceuticals Ltd. | Mainboard | ₹582.11 Cr | ₹391 | 39.77 | ₹557.80 | +42.66% | ₹1,405.10 (-3.68%) |
| Sai Life Sciences Ltd. | Mainboard | ₹3,042.62 Cr | ₹549 | 126.42 | ₹764.65 | +39.28% | ₹1,272.00 (-1.60%) |
| Akums Drugs & Pharmaceuticals Ltd. | Mainboard | ₹1,856.74 Cr | ₹679 | null | ₹796.25 | +17.27% | ₹664.95 (-2.60%) |
| Emcure Pharmaceuticals Ltd. | Mainboard | ₹1,952.03 Cr | ₹1008 | 34.55 | ₹1,359.15 | +34.84% | ₹1,783.20 (-1.07%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division | 22.60 |
| 2 | Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division | 11.59 |
| 3 | Purchase of Machineries for Homecare and Cosmetic Division | 2.76 |
| 4 | General Corporate Purposes | 5.44 |
| 5 | Issue Expenses | 5.83 |
| Total | 48.21 |
About Influx Healthtech IPO
Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specialising in contract manufacturing. The company is a reliable CDMO, providing specialized services to clients in multiple industries. The company has three manufacturing facilities in Thane, Maharashtra, each covering an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively. Product Portfolio: Tablets, Capsules, and Powders Liquid Orals and Softgels Lozenges, Jellies, and Gummies Oral Dispersible Films (ODFs) Effervescent Tablets and Liquid-Fill Capsules Candies and Gym/Sports Supplements Skin Care and Body Care Products Hair Care and Beard Care Solutions Face Masks and Soaps. Ayurvedic / Herbal formulations Veterinary Feed Supplements Homecare solutions The Company aids Nutraceutical and Cosmetic firms with product development and manufacturing. It offers end-to-end services, including development, production, and regulatory support, enabling clients to focus on formulation and commercialization. As of June 11, 2025, the company has 163 permanent employees on a payroll basis. Competitive Strength Diversified Product Portfolio Diverse Clientele Stringent Quali
Contact Details
Influx Healthtech Ltd. Address109, Ghanshyam Enclave Premises Co-opSoc Plot No.856, LaljipadaKandivali (West)Mumbai, Maharashtra, 400067+91 7045997809cs@influxhealthtech.comVisit Website